Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost.
van der Valk Rikkert, Webers Carroll A B, Hendrikse Fred, de Vogel Stefan C, Prins Martin H, Schouten Jan S A G
AI Summary
This study found timolol and latanoprost provide similar IOP reduction in practice. Importantly, routine patient data, beyond baseline IOP, cannot reliably predict individual treatment response for glaucoma management.
Abstract
Purpose
To study intraocular pressure (IOP) reductions with timolol and latanoprost reached in clinical practice, taking into account data that are routinely collected by the ophthalmologist; to predict IOP reduction from these variables.
Methods
A cohort of patients with primary open-angle glaucoma (suspect) or ocular hypertension was recruited from nine Dutch centres. Mean absolute and relative IOP reduction was calculated in order to compare timolol to latanoprost. IOP reduction was calculated by comparing patients with certain characteristics to those who had none.
Results
One hundred and fifty-six persons started on timolol and 76 started on latanoprost monotherapy. Mean [95% confidence interval (CI)] absolute reduction was 7.2 mmHg (7.9; 6.5) for timolol and 6.9 mmHg (8.0; 5.8) for latanoprost. Mean relative reduction (95% CI) was 27.2% (29.3; 25.1) for timolol and 26.6% (30.2; 22.9) for latanoprost. No significant difference in IOP reduction between timolol and latanoprost was found when adjusting for data that are routinely collected by the ophthalmologist. At the time of starting treatment, none of these items normally used for the management of glaucoma, except IOP at baseline, could predict change in IOP.
Conclusion
In clinical practice, timolol and latanoprost achieve similar IOP reductions that are comparable to those achieved in randomized trials. No clinically relevant information for glaucoma management can be used to predict IOP reduction accurately.
MeSH Terms
Shields Classification
Related Articles5
Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. I. Aqueous humor dynamics.
Basic ScienceA comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.
Randomized Controlled TrialA double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure.
Randomized Controlled TrialAdditive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure.
Randomized Controlled TrialThe efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension.
Randomized Controlled TrialIs this article assigned to the wrong chapter(s)? Let us know.